Experience

Davis Polk advised Afya Limited on its SEC-registered follow-on offering of an aggregate of 12,426,740 Class A common shares, of which 3,019,928 shares were issued and sold by Afya and…

Davis Polk advised the representatives of the several underwriters in connection with the SEC-registered offering of 6,500,000 shares of common stock of Applied Genetic Technologies…

Davis Polk advised the underwriters in connection with a public offering by International Business Machines Corporation of €1.3 billion principal amount of its 0.300% notes due 2028, €1.6…

Davis Polk advised the underwriters in connection with a $75 million public offering of common stock by RAPT Therapeutics, Inc. RAPT Therapeutics’ common stock is listed on the …

Davis Polk advised SMART Global Holdings, Inc. in connection with a Rule 144A offering of $250 million aggregate principal amount of its 2.25% convertible senior notes due 2026. Davis Polk…

Davis Polk advised Uniti Group Inc. in connection with a Rule 144A and Regulation S offering of $2.25 billion aggregate principal amount of 7.875% senior secured notes due 2025 issued by…

Davis Polk advised the joint book-running managers in connection with the $180 million initial public offering of common stock of Beam Therapeutics Inc. The common stock is listed on the…

Davis Polk advised Clarivate Analytics Plc in connection with the $559 million SEC-registered offering of 27,600,000 of its ordinary shares. The ordinary shares are listed on the New York…

Davis Polk advised the joint book-running managers and representatives of the underwriters on an SEC-registered offering by Stanley Black & Decker, Inc. of $750 million aggregate…

Davis Polk advised the underwriter in connection with the $59.9 million secondary offering of 2,678,049 shares of common stock of TriState Capital Holdings, Inc. by selling shareholders LM…